Health experts warned that while McDonald’s expansion into regional Australia in the next two years would bode well for local economies, it would not be good for their population’s health.
About a third of the 100 McDonald’s Australia restaurants set to open in the next two years will be in regional and remote areas.
Cameron Newlands, a senior director of the restaurant group, said population growth and government and private investment in regional areas were driving where they would open.
Newlands said the average McDonald’s restaurant fills about 120 full-time, part-time, and casual jobs across different roles from kitchen, service, and management roles in each town, which is substantial in terms of employment opportunity.
But the move is controversial in towns battling obesity and related diseases.
Megan Belot, the president of the Rural Doctors Association of Australia, said that while it’s nice to think that McDonald’s would provide more jobs and opportunities for our younger people, they don’t need fast food in our smaller rural communities who already have an increased risk of obesity.
Belot said the focus for regional communities should be on better access to more fresh food and vegetables and meat.
Dr. Kim Houghton, the chief economist at the Regional Australia Institute, said McDonald’s may be increasingly drawn to the regions as they weren’t as affected by those capital city lockdowns in 2020 due to Covid and bounced back much faster than the city.
Erica Spry, an Aboriginal research officer for the Kimberley Aboriginal Medical Services, said she was very concerned about the effect of fast-food restaurants on the indigenous population, who are seeing increasing rates of diabetes across multiple generations.
Research by Spry and Julia Marley, professor of health research at the rural clinical school of the University of Western Australia, shows Indigenous populations in rural and remote populations can have three times the average rate of diabetes as the general population.


FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Gold and Silver Prices Plunge as Trump Taps Kevin Warsh for Fed Chair
Russia Stocks End Flat as MOEX Closes Unchanged Amid Mixed Global Signals
Dollar Holds Firm as Markets Weigh Warsh-Led Fed and Yen Weakness Ahead of Japan Election
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
U.S.–Venezuela Relations Show Signs of Thaw as Top Envoy Visits Caracas
South Korea Exports Surge in January on AI Chip Demand, Marking Fastest Growth in 4.5 Years
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 



